Summit Therapeutics SMMT Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Summit Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Summit Therapeutics’s 10-Q, filed August 6, 2024, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's price / sales?
- Summit Therapeutics (SMMT) reported price / sales of 8,008.9× in Q2 2023.
- How has Summit Therapeutics's price / sales changed year-over-year?
- Summit Therapeutics's price / sales increased by 2233.2% year-over-year, from 343.3× to 8,008.9×.
- What is the long-term trend for Summit Therapeutics's price / sales?
- Over 2 years (2020 to 2022), Summit Therapeutics's price / sales has grown at a 5.0% compound annual growth rate (CAGR), from 3,836.4× to 4,231.8×.
- What does price / sales mean?
- How many dollars investors pay for each dollar of the company's annual sales.
- How do you interpret price / sales?
- Useful when earnings are negative or volatile (e.g. early-stage or cyclical firms). Only comparable across companies with similar margins — a sales dollar is worth more at a high-margin business.
- How does price / sales compare across companies?
- Best compared within a margin cohort; a software P/S and a retailer P/S are not directly comparable.